BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2024 9:30:57 AM | Browse: 112 | Download: 906
 |
Received |
|
2024-06-10 13:04 |
|
Peer-Review Started |
|
2024-06-10 13:04 |
|
First Decision by Editorial Office Director |
|
2024-08-13 20:00 |
|
Return for Revision |
|
2024-08-14 23:36 |
|
Revised |
|
2024-09-02 13:16 |
|
Publication Fee Transferred |
|
2024-10-30 13:24 |
|
Second Decision by Editor |
|
2024-10-28 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-28 07:22 |
|
Articles in Press |
|
2024-10-28 07:22 |
|
Edit the Manuscript by Language Editor |
|
2024-11-11 05:16 |
|
Typeset the Manuscript |
|
2024-11-21 03:46 |
|
Publish the Manuscript Online |
|
2024-12-12 09:30 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Interleukin-17A facilitates tumor progression via upregulating programmed death ligand-1 expression in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhong-Xia Yang, Li-Ting Zhang, Xiao-Jun Liu, Xue-Bin Peng and Xiao-Rong Mao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Gansu Province |
No. 21JR7RA373 |
| Natural Science Foundation of Gansu Province |
No. 24JRRA295 |
|
| Corresponding Author |
Xiao-Rong Mao, Chief Physician, Department of Infectious Diseases, The First Hospital of Lanzhou University, No. 1 Donggangxi Road, Chengguan District, Lanzhou 730000, Gansu Province, China. layygrk@126.com |
| Key Words |
Interleukin-17A; Programmed death ligand-1; Interleukin-17A receptor; Small mothers against decapentaplegic 2; Hepatocellular carcinoma; Immunotherapy |
| Core Tip |
Over expression of programmed death ligand-1 (PD-L1) on tumor cells promote cancer immune escape through inhibiting T cell function. Interleukin-17A (IL-17A) can increase the expression of PD-L1 in tumor cells and promote tumor progression. However, related research in hepatocellular carcinoma (HCC) is scared. In this study, we clarified a novel mechanism that IL-17A upregulated PD-L1 expression in HCC cells by IL-17A receptor/phosphorylation-small mothers against decapentaplegic 2 axis. IL-17A could drive the immune escape of HCC cells. IL-17A also promoted the proliferation, migration, and angiogenesis of HCC cells, while inhibited the apoptosis of HCC cells. IL-17A inhibitor enhanced the therapeutic efficacy of PD-L1 antibody in HCC in vivo. |
| Publish Date |
2024-12-12 09:30 |
| Citation |
Yang ZX, Zhang LT, Liu XJ, Peng XB, Mao XR. Interleukin-17A facilitates tumor progression via upregulating programmed death ligand-1 expression in hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(1): 97831 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i1/97831.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i1.97831 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
